Statistics
Publications
1
Citations
18
H-Index
1
Active since
2023
Affiliations
Frontier Medicines (United States)(Current)
Daniel Erlanson is an author at Frontier Medicines (United States) specializing in oncogenic signaling pathways, drug discovery, and oncology.
Publications per year
2023–2023
1
1
1–1 of 1